Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Treatment of shoulder spasticity in stroke patients using shock wave therapy

Official title: Effects of Extracorporeal Shock Wave Therapy on Shoulder Internal Rotator Spasticity in Post-Stroke Patients: A Randomized Controlled Trial

Run by National Taiwan University Hospital · NCT06674785 · Data updated 2026-11-12

This study is testing if shock wave therapy can help stroke patients with tight shoulder muscles feel better and move their arms more easily.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorNational Taiwan University Hospital
Academic / other
Locations1 site (Taipei)
StatusRecruiting
StartedJuly 23, 2025
Main results expectedDecember 31, 2026
Study endsDecember 31, 2027
Registry record updatedJuly 29, 2025
Trial IDNCT06674785 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who have experienced a unilateral cerebral stroke and exhibit significant shoulder internal rotator spasticity.

Probably not a fit

Patients with a history of multiple strokes, other central nervous system disorders, or those who have recently received similar treatments may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial evaluates the effectiveness of focused extracorporeal shock wave therapy (ESWT) on shoulder internal rotator spasticity in patients who have suffered a stroke. Participants are randomly assigned to receive either the actual ESWT treatment or a placebo treatment that mimics the therapy. The treatment is administered twice weekly over two weeks, totaling four sessions, and various assessments are conducted to measure outcomes such as range of motion, pain levels, and functional abilities. The study aims to determine both the immediate and long-term effects of the therapy on shoulder function and spasticity.

Why it matters

Potential benefit: If successful, this therapy could significantly improve shoulder function and reduce spasticity in stroke survivors, enhancing their quality of life.

How similar studies have gone: Previous studies have shown promise for extracorporeal shock wave therapy in reducing spasticity, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 18 years or older with unilateral cerebral stroke.
* Restricted passive external rotation of the spastic shoulder by more than 20 degrees.
* A Modified Ashworth Scale score of 1 or higher for shoulder internal rotator spasticity.
* Stable medical condition and vital signs.
* Clear consciousness, able to follow instructions.

Exclusion Criteria:

* History of two or more strokes, traumatic brain injury, brain tumors, or other cerebral disorders.
* Coexisting central nervous system disorders (e.g., spinal cord injury, Parkinson's disease) or other musculoskeletal conditions affecting muscle tone assessment.
* Ineligibility for shock wave intervention due to malignancies, coagulation disorders, localized infections, or presence of a pacemaker.
* Prior shock wave intervention or botulinum toxin injection for post-stroke spasticity within the past three months.
* Inability to participate in interventions or functional assessments due to cognitive, consciousness, or language impairments.

Where it's running

  • Department of Physical Medicine & Rehabilitation , National Taiwan University Hospital
    Taipei, Taiwan
    Recruiting

Study contacts

  • Principal investigator: Shu-mei Yang, MD — National Taiwan University Hospital
  • Study coordinator: Shu-mei Yang, MD
  • Email: b99401109@gmail.com
  • Phone: 0972653675

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.